Caregivers and healthcare providers, help us better understand frontotemporal dementia and related disorders in Canada!
Click the survey link – only 5 minutes to complete.
🔗 Survey Link: https://t.co/bk2plO2Tm5
Your insights matter! 🧠💪
#FTD#11thCCD
📣 Exciting news for #11thCCD attendees! The CIHR and CCD have partnered to provide Travel Grants of up to $500 for students, post-docs, and researchers in dementia studies.
❗️ Don't miss out - apply by September 22nd.
For more details, click here: https://t.co/clflqruHY8 🌐
⏳ Time is ticking!
Act fast to save with Early Registration Rates until Sep 21. Secure your spot at the 11th Canadian Conference on Dementia happening Nov 2-4, 2023.
📩 Questions? Reach out to [email protected]#CCD2023#11thCCD
🚨 Abstract Submission Deadline EXTENDED!!
Don't miss the chance to present your research at the 11th Canadian Conference on Dementia! #CCD2023#11thCCD
🗓️ EXTENDED DEADLINE: July 31st, 2023, 11:59 pm Eastern
Submit your abstract now: https://t.co/1j93POm8vt
📣 REMINDER!
Don't miss the chance to present your research at the 11th Canadian Conference on Dementia! Submit your abstract by clicking on the link below:
📅 Abstract submission deadline: July 28, 2023.
https://t.co/1j93POm8vt
🌐 Learn more: https://t.co/n4ifEdABEw
#11thCCD
Hello all CCD Twitter is alive again, in advance of the 11th CCD in Toronto Nov 2-4. Logo will be updated soon. Abstract submissions are open too. See you there!!!
Check out @NeuroPsychPIA executive committee member @byron_creese 's new commentary in @NatRevNeurol with Katie Lunnon, "Neuropsychiatric symptoms in #AlzheimersDisease the search for mechanisms" 📖
https://t.co/rHGiKsqexU
The next 30 years will see a near 200% increase in the # of middle-aged people caring for parents & grandparents living with #dementia while balancing childcare, work and other responsibilities.
Learn more in the #LandmarkStudy: https://t.co/Mh2n30BeK9
Congrats to Dr. Sam Weiss for being inducted into the 2023 @CdnMedHallFame. @RockyMtnBrain has been a trailblazer in establishing neurogenesis research as a pathway to treatments for diseases like Parkinson’s, Alzheimer’s, stroke, ALS, and MS.
@UCalgaryMed https://t.co/ub8VGbAYx7
Persistent episodes of #psychosis in mid-to-late life in cognitively normal people increases the risk for #dementia, according to new research by Dr. Zahinoor Ismail and his research collaborators.
See more on these important research findings at: https://t.co/AGV6VI8dfe
The presence of apathy in those with mild behavioral impairment (MBI) increases the risk of progression rate to dementia - Dr. Zahinoor Ismail presents @ the 2022 Alzheimer’s Association International Conference (AAIC):
https://t.co/EbQ9s1GnSo
#dementia#brainresearch
Today at #AAIC22, ADDF-supported researcher @KristaLanctot of @Sunnybrook will discuss her work on #apathy in neurodegenerative diseases in a plenary session. The #ADDF has funded Dr. Lantot's work since 2014.
See the statement from @AlzCanada regarding media reports of possible misconduct in research on the potential causes for #Alzheimer’s disease.
https://t.co/BZFn3mYCtI
Each monthly instalment of #DementiaTalksCanada centres on people with direct experience of the topic, from #youngonsetdementia to new technologies and more! Listen to past topics and register for upcoming convos at https://t.co/SKIM7aX0AB!
Did you know that you can include @AlzCanada in your Will?
By doing so, you can help save and change lives for generations to come.
Visit https://t.co/d3FjX70hYJ to read our summer newsletter for more information on Will planning.
With #neurodegenerative diseases and #dementia, we tend to think of our #seniors population. Yet, many people are diagnosed at a much younger age with #youngonset of disease. More on the complexity of diagnosis, adapted from guidelines by @MarioMasellis https://t.co/vT5Zr0yXik